Related Experiment Videos
Cutaneous tuberculosis: diagnosis and treatment
Joseph Barbagallo1, Patricia Tager, Rosemary Ingleton
1Department of Dermatology, St Luke's-Roosevelt Hospital Center, New York, New York 10025, USA.
American Journal of Clinical Dermatology
|June 19, 2002
Summary
Cutaneous tuberculosis is re-emerging, particularly in HIV-infected individuals and those with drug-resistant tuberculosis. Early diagnosis and treatment are crucial for managing this complex skin disorder.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Cutaneous tuberculosis (TB) is re-emerging globally, especially in regions with high HIV prevalence and multi-drug resistant pulmonary TB.
- Caused by Mycobacterium tuberculosis, Mycobacterium bovis, or BCG vaccine, skin TB presents with diverse lesions.
- Diagnosis is challenging, requiring clinical correlation with microbiological tests.
Purpose of the Study:
- To review the re-emergence of cutaneous TB.
- To discuss diagnostic methods and treatment strategies.
- To emphasize the importance of increased awareness for timely management.
Main Methods:
- Review of existing literature on cutaneous tuberculosis.
- Analysis of diagnostic techniques including Acid-Fast Bacilli (AFB) stains, culture, and Polymerase Chain Reaction (PCR).
- Discussion of clinical presentations and treatment approaches.
Main Results:
- Cutaneous TB lesions manifest in various forms, including tuberculous chancre, lupus vulgaris, and tuberculids.
- PCR offers rapid, sensitive, and specific diagnosis compared to traditional methods.
- Treatment regimens are similar to systemic TB, with prompt initiation critical in immunocompromised patients.
Conclusions:
- Cutaneous TB is a significant manifestation of systemic disease, often with lower bacillary load than pulmonary TB.
- Rapid diagnosis and treatment are paramount, especially in HIV-positive individuals.
- Increased awareness is essential for effective diagnosis and management of this growing public health concern.